Source comparison
TB-500 Blood Work Labs Before and After: Comparison Table
Before interpreting lab changes, compare baseline to post-cycle values across the markers TB-500 directly affects. The table below shows expected numerical ranges, typical shifts, and interpretation thresholds. Platelet Count 150,000–400,000/µL 180,000–250,000
This comparison does not assign a generated winner or score.
- Before interpreting lab changes, compare baseline to post-cycle values across the markers TB-500 directly affects. The table below shows expected numerical ranges, typical shifts, and interpretation thresholds.
- Platelet Count
- 150,000–400,000/µL
- 180,000–250,000/µL
- +15–40% (25,000–80,000/µL increase)
- >450,000/µL or <130,000/µL
- Platelet elevation is the most consistent TB-500 response. Values above 450,000/µL warrant hematology consultation to rule out essential thrombocythemia
- ALT (Liver Enzyme)
- 7–56 U/L
- <30 U/L
- +10–25% (transient, weeks 2–4)
- >80 U/L sustained
- Mild transient elevation is expected. Sustained values >80 U/L suggest pre-existing liver pathology or drug interaction
- AST (Liver Enzyme)
- 10–40 U/L
- <25 U/L
- +10–20% (transient, weeks 2–4)
- >65 U/L sustained
- AST elevations parallel ALT. Disproportionate AST elevation (AST:ALT ratio >2:1) suggests muscle breakdown, not liver stress
- hs-CRP
- <1.0 mg/L (low risk)
- <2.0 mg/L
- −30–50% reduction
- >3.0 mg/L or no change from baseline
- TB-500 should lower inflammatory markers. Failure to reduce or paradoxical increase indicates undiagnosed inflammatory condition
- Creatinine
- 0.7–1.3 mg/dL
- 0.8–1.1 mg/dL
- No significant change
- >1.5 mg/dL or >20% increase
- Creatinine should remain stable. Elevation suggests dehydration or renal impairment unrelated to TB-500
- eGFR (Kidney Function)
- >90 mL/min/1.73m²
- <60 mL/min/1.73m²
- Peptides are renally cleared. Reduced eGFR requires dose adjustment or discontinuation